Breast cancer cell growth halted by osteoporosis drug, study shows
by Ian Sample Science editor from on (#1HSV6)
A trial in mice has shown that the drug denosumab could become a preventative breast cancer treatment for women with BRCA1 gene mutations
Women who have a high risk of breast cancer may benefit from a drug that is already prescribed to treat bone loss in old age, according to scientists in Australia.
Researchers found that the osteoporosis drug, denosumab, can halt the growth of cells which give rise to breast tumours in women whose risk of the disease is greater because of mutations in a gene called BRCA1.